Atara Biotherapeutics Inc ATRA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:51 PM EDT
0.58quote price arrow down-0.0226 (-3.7504%)
Volume
965,673
52 week range
0.20 - 3.02
Loading...
  • Open0.5977
  • Day High0.6063
  • Day Low0.57
  • Prev Close0.6026
  • 52 Week High3.02
  • 52 Week High Date05/08/23
  • 52 Week Low0.20
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap69.841M
  • Shares Out120.42M
  • 10 Day Average Volume1.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change13.1

KEY STATS

  • Open0.5977
  • Day High0.6063
  • Day Low0.57
  • Prev Close0.6026
  • 52 Week High3.02
  • 52 Week High Date05/08/23
  • 52 Week Low0.20
  • 52 Week Low Date11/13/23
  • Market Cap69.841M
  • Shares Out120.42M
  • 10 Day Average Volume1.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change13.1

RATIOS/PROFITABILITY

  • EPS (TTM)-2.61
  • P/E (TTM)-0.22
  • Fwd P/E (NTM)-0.92
  • EBITDA (TTM)-264.447M
  • ROE (TTM)-2,014.86%
  • Revenue (TTM)8.573M
  • Gross Margin (TTM)-3.65%
  • Net Margin (TTM)-3,220.88%
  • Debt To Equity (MRQ)-35.84%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Atara Biotherapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company. The Company is a developer of T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. Its pipeline products include Ebvallo (Tab-cel), ATA3219. The Company’s T-cell immunotherapy, tab-cel (tabelecleucel), is in Phase III...
Carol Gallagher Pharm.D.
Independent Chairman of the Board
Pascal Touchon
President, Chief Executive Officer, Director
Eric Hyllengren
Chief Financial Officer, Senior Vice President, Investor Relations and Finance
K. Amar Murugan
Executive Vice President, Chief Legal Officer
Address
2380 Conejo Spectrum St, Suite 200
Thousand Oaks, CA
91320
United States

Top Peers

SYMBOLLASTCHG%CHG
LVTX
LAVA Therapeutics NV
3.04+0.04+1.35%
AFMD
Affimed NV
5.21-0.03-0.48%
CLSD
Clearside Biomedical Inc
1.27-0.01-0.78%
CRIS
Curis Inc
16.25+0.05+0.34%
JAGX
Jaguar Health Inc
0.2677-0.0303-10.1678%